Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002069422 | SCV002402252 | likely benign | not provided | 2024-03-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035464 | SCV004930025 | likely benign | Inborn genetic diseases | 2023-11-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001278169 | SCV001465165 | uncertain significance | Epidermolysis bullosa dystrophica inversa, autosomal recessive | 2020-09-11 | no assertion criteria provided | clinical testing |